[1] |
European Association for the Study of the Liver. EASL clini-cal practice guidelines:vascular diseases of the liver[J]. J Hepatol, 2016, 64(1):179-202.
DOI
URL
|
[2] |
Sakumura M, Tajiri K, Miwa S, et al. Hepatic sinusoidal obstruction syndrome induced by non-transplant chemotherapy for non-Hodgkin lymphoma[J]. Intern Med, 2017, 56(4):395-400.
DOI
URL
|
[3] |
Tripathi D, Stanley AJ, Hayes PC, et al. Transjugular intrahepatic portosystemic stent-shunt in the management of portal hypertension[J]. Gut, 2020, 69(7):1173-1192.
DOI
PMID
|
[4] |
di Giorgio A, Agazzi R, Alberti D, et al. Feasibility and efficacy of transjugular intrahepatic portosystemic shunt(TIPS) in children[J]. J Pediatr Gastroenterol Nutr, 2012, 54(5):594-600.
DOI
URL
|
[5] |
Zhou CZ, Wang RF, Lv WF, et al. Transjugular intrahepatic portosystemic shunt for pyrrolizidine alkaloid-related hepatic sinusoidal obstruction syndrome[J]. World J Gastroenterol, 2020, 26(24):3472-3483.
DOI
URL
|
[6] |
诸葛宇征, 王烜. 吡咯生物碱相关肝窦阻塞综合征研究进展[J]. 实用肝脏病杂志, 2021, 24(5):617-620.
|
|
Zhuge YZ, Wang H. Research progress of pyrrole alkaloid-associated hepatic sinus obstruction syndrome[J]. J Prac Hepatol, 2021, 24(5):617-620.
|
[7] |
宋青青, 罗方伶, 唐倩, 等. 低分子肝素皮下注射操作的最佳证据总结[J]. 中华护理杂志, 2023, 58(2):232-237.
DOI
|
|
Song QQ, Luo FL, Tang Q, et al. Evidence summary for subcutaneous injection of low molecular weight heparin[J]. Chin J Nurs, 2023, 58(2):232-237.
DOI
|
[8] |
中华医学会消化病学分会肝胆疾病协作组. 吡咯生物碱相关肝窦阻塞综合征诊断和治疗专家共识意见(2017年,南京)[J]. 临床肝胆病杂志, 2017, 33(9):1627-1637.
|
|
Cooperative Group for Hepatic and Gall Diseases, Chinese Society of Gastroenterology, Chinese Medical Association. Expert consensus on diagnosis and treatment of pyrrolidine alkaloids-related sinusoidal obstruction syndrome(2017,Nanjing)[J]. J Clin Hepatol, 2017, 33(9):1627-1637.
|
[9] |
Nauffal M, Kim HT, Richardson PG, et al. Defibrotide:real-world management of veno-occlusive disease/sinusoidal obstructive syndrome after stem cell transplant[J]. Blood Adv, 2022, 6(1):181-188.
DOI
URL
|
[10] |
尚昀晛, 韩雪莉, 曾巧玲, 等. 1例门腔静脉半转位肝移植术后患者并发胆漏及十二指肠漏的护理[J]. 中华护理杂志, 2021, 56(2):260-264.
DOI
|
|
Shang YX, Han XL, Zeng QL, et al. Nursing care of a patient with bile leakage and duodenal leakage in liver transplanta-tion with portal vein semi transposition[J]. Chin J Nurs, 2021, 56(2):260-264.
|
[11] |
张晓静, 张会芝, 周玉洁, 等. 住院患者非计划性拔管风险评估体系的建立[J]. 中华护理杂志, 2015, 50(11):1331-1334.
|
|
Zhang XJ, Zhang HZ, Zhou YJ, et al. Establishment of risk assessment system for unplanned extubation of inpatients[J]. Chin J Nurs, 2015, 50(11):1331-1334.
|
[12] |
吕一帆, 刘福全. 经颈静脉肝内门体分流术后抗凝治疗现状[J]. 中国介入影像与治疗学, 2021, 18(10):622-626.
|
|
Lü YF, Liu FQ. Status of anticoagulant therapy after transjugular intrahepatic portosystemic shunt[J]. Chin J Interv Imaging Ther, 2021, 18(10):622-626.
|
[13] |
李国宏, 冯英璞, 李双喜, 等. 门脉高压患者门体支架植入围术期营养管理专家共识(2020)[J]. 介入放射学杂志, 2021, 30(3):217-224.
|
|
Li GH, Feng YP, Li SX, et al. Expert consensus on perioperative nutrition management of portal stenting in patients with portal hypertension[J]. J Interv Radiol, 2021, 30(3):217-224.
|
[14] |
Xiao JQ, Tu JJ, Zhang H, et al. Risk factors of poor prognosis in patients with pyrrolidine alkaloid-induced hepatic sinusoidal obstruction syndrome after transjugular intrahepatic portosystemic shunt[J]. Hepatol Int, 2021, 15(3):720-729.
DOI
PMID
|